Healthcare & Life Sciences
LabGenius Therapeutics
United Kingdomlabgeniustx.com/
LabGenius Therapeutics is a startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About LabGenius Therapeutics
LabGenius Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
LabGenius Therapeutics develops therapeutic antibodies using an automated, machine-learning-driven discovery platform called EVA to identify and co‑optimize complex antibody molecules across multiple properties. The company is focused on creating selectivity‑enhanced antibodies, including multispecific formats, for the treatment of solid tumours.
Explore LabGenius Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.